International Journal of Drug Delivery Technology
Volume 14, Issue 1

Current Insights of Nano Suspension Drug Delivery System: A Patent Review

D Jeslin*, K Masilamani

Department of Pharmaceutics, Faculty of Pharmacy, Sree Balaji Medical College and Hospital Campus, Bharath Institute of Higher Education and Research, Selaiyur, Chennai, India. 

Received: 11th September, 2023; Revised: 01st December, 2023; Accepted: 16th December, 2023; Available Online: 25th March, 2024

ABSTRACT

Unfortunately, water-solvency continues to be a usual characteristic of medication newcomers in medicine improvement pipelines today. Different cycles have been established to improve the solvency, disintegrating rate, and bioavailability associated with these dynamic fixes having a place utilizing the biopharmaceutics classification system (BCS) II through IV orders. Since the mid-2000s, nanosuspension, nanocrystal delivery, and nebulous strong scatterings have been more established approaches to overcome the obstructions of ineffective water solvent pharmaceuticals in food and drug administration (FDA) accessible goods. This work supplies a refreshed examination of nanosuspension and dissimilar strong scattering methods, particularly for orally conveyed medications. Moreover, solvency is a vital variable for medication adequacy, autonomously of the course of development. Ineffectively solvent drugs are many times difficult assignments for developers within the sector. Customary methods to improve solvency are of little significance, specifically when the pharmaceuticals are ineffectively liquid all the while they’re watery as well as non-fluid mediums. Nanosuspension technology can be employed to enhance the potency and solubility with insoluble substances medicines. Nanosuspension possesses dual-phase structures made up of precise medication particles scattered throughout a liquid medium kept in check with surfactants. Those strategies generally straightforward plan offer advantages compared to alternative methods. Various methods, comprising wet manufacturing, regions assembling, emulsifying, evaporating the solvent, and releasing simple liquid methods, are employed when making nanosuspension. Subsequently enjoys convenience conveyance via diverse courses, comprising oral, parenteral, aspiratory even visual courses. The current proposal plan provide the ongoing strategies employed to get ready small suspensions, including their application in medication conveyance.

Keywords: Amorphous solid dispersion, Solubility enhancement, Nanosuspension, Oral drug delivery, Bioavailability. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.70

How to cite this article: Jeslin D, Masilamani K. Current Insights of Nano Suspension Drug Delivery System: A Patent Review. International Journal of Drug Delivery Technology. 2024;14(1):506-514.

Source of support: Nil.

REFERENCES

  1. Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: Preparation by a size-reduction technique. International journal of pharmaceutics. 1998 Jan 26;160(2):229-Available from: doi.org/10.1016/S0378-5173(97)00311-6
  2. Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, Yun J. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. International journal of pharmaceutics. 2007 Sep 5;342(1-2):26-32. Available from: org/10.1016/j.ijpharm.2007.04.025
  3. Zhang X, Xia Q, Gu N. Preparation of all-trans retinoic acid nanosuspensions using a modified precipitation method. Drug development and industrial 2006 Jan 1;32(7):857-63. Available from: doi.org/10.1080/03639040500534184
  4. Kocbek P, Baumgartner S, Kristl Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. International journal of pharmaceutics. 2006 Apr 7;312(1- 2):179-86. Available from: doi.org/10.1016/j.ijpharm.2006.01.008
  5. Möschwitzer J, Achleitner G, Pomper H, Müller Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. European Journal of Pharmaceutics and Biopharmaceutics. 2004 Nov 1;58(3):615-9. Available from: doi.org/10.1016/j. ejpb.2004.03.022
  6. Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. Journal of pharmacy and pharmacology. 2004 Jul;56(7):827-40. Available from: doi. org/10.1211/0022357023691
  7. Choi SW, Kim WS, Kim Surface modification of functional nanoparticles for controlled drug delivery. Journal of dispersion science and technology. 2003 Jan 7;24(3-4):475-87. Available from: doi.org/10.1081/DIS-120021803
  8. Itoh K, Pongpeerapat A, Tozuka Y, Oguchi T, Yamamoto K. Nanoparticle formation of poorly water-soluble drugs from ternary ground mixtures with PVP and SDS. Chemical and pharmaceutical 2003;51(2):171-4. Available from: doi. org/10.1248/cpb.51.171
  9. Wongmekiat A, Tozuka Y, Oguchi T, Yamamoto K. Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of β-cyclodextrin anhydrate and hydrate. Pharmaceutical 2002 Dec;19:1867-72. Available f rom: doi. org/10.1023/a:1021401826554
  10. Miller-Chou BA, Koenig JL. A review of polymer dissolution. Progress in polymer 2003 Aug 1;28(8):1223-70. Available from: doi.org/10.1016/S0079-6700(03)00045-5
  11. Evans DF, Wennerström The colloidal domain: where physics,chemistry, biology, and technology meet.1999.
  12. Mosharraf M, Nyström C. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. International journal of pharmaceutics. 1995 Aug 1;122(1-2):35-47. Available from: doi.org/10.1016/0378- 5173(95)00033-F
  13. Jacobs C, Müller RH. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharmaceutical research. 2002 Feb;19:189-94. Available from:doi.org/10.1023/a:1014276917363
  14. Liang Y, Binner J. Effect of triblock copolymer non-ionic surfactants on the rheology of 3 mol% yttria stabilised zirconia Ceramics international. 2008 Mar 1;34(2):293-Available from: doi.org/10.1016/j.ceramint.2006.10.002
  15. Duchêne D, Ponchel G. Bioadhesion of solid oral dosage forms, why and how?. European Journal of Pharmaceutics and Biopharmaceutics. 1997 Jul 1;44(1):15-23. Available from: org/10.1016/S0939-6411(97)00097-0
  16. Van Oss CJ, Absolom DR, Neumann AW. Interaction of phagocytes with other blood cells and with pathogenic and nonpathogenic Annals of the New York Academy of Sciences. 1983 Jan 1;416:332-50. Available from: doi. org/10.1111/j.1749-6632.1983.tb35197.x
  17. Wallis KH, Müller RH. Determination of the surface hydrophobicity of colloidal dispersions by mini-hydrophobic interaction chromatography. Pharmazeutische Industrie. 1993;55(12):1124-8.
  18. Ahmed TY, Liqa’a Thermodynamic Study of Adsorption of Tamoxifen Drug on Activated Nano-Coal Particles prepared from Stem of Eucalyptus and its Diagnosis by different Techniques. IJDDT10. 2020(3,239-241) Available from: doi.org/10.25258/ ijddt.10.3.3.
  19. Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery Biomaterials research. 2020 Dec;24:1-6. Available from: doi.org/10.1186/s40824-020-0184-8
  20. He S, Yang H, Zhang R, Li Y, Duan Preparation and in vitro– in vivo evaluation of teniposide nanosuspensions. International journal of pharmaceutics. 2015 Jan 15;478(1):131-7. Available from: doi.org/10.1016/j.ijpharm.2014.11.020
  21. Weder HG, Van Hoogevest P, inventors; Novartis Corp, Nanosuspensions for intravenous administration. United States patent US 5,726,164. 1998 Mar 10. Available from: doi. org/10.4103%2F2231-4040.82950
  22. Farooq MA, Xu L, Aquib M, Ahsan A, Baig MM, Wang B. Denatured food protein-coated nanosuspension: A promising approach for anticancer delivery of hydrophobic drug. Journal of molecular liquids. 2020 Apr 1; 303:112690. Available from: org/10.1016/j.molliq.2020.112690
  23. Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug Journal of controlled release. 2013 Dec 28;172(3):1126-41. Available from: doi.org/10.1016/j. jconrel.2013.08.006
  24. Wang Y, Li X, Wang L, Xu Y, Cheng X, Wei Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery. International journal of nanomedicine. Available from: doi.org/10.2147%2FIJN.S21097
  25. Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery Biomaterials research. 2020 Dec;24:1-6. Available from: doi.org/10.1186/s40824-020-0184-8
  26. Pu X, Sun J, Li M, He Z. Formulation of nanosuspensions as a new approach for the delivery of poorly soluble drugs. Current nanoscience. 2009 Nov 1;5(4):417-27. Available from: doi. org/10.1155/2015/216375
  27. Balanč B, Đorđević V, Marković S, Pjanović R, Nedović V, Bugarski Novel resveratrol delivery systems based on alginate- sucrose and alginate-chitosan microbeads containing liposomes. Food Hydrocolloids. 2016 Dec 1;61:832-42.Available from: doi. org/10.1016/j.foodhyd.2016.07.005
  28. Szabó E, Démuth B, Galata DL, Vass P, Hirsch E, Csontos I, Marosi G, Nagy Continuous formulation approaches of amorphous solid dispersions: significance of powder flow properties and feeding performance. Pharmaceutics. 2019 Dec 5;11(12):654. Available from: doi.org/10.3390%2Fpharmaceut ics11120654
  29. Lammers T, Subr V, Ulbrich K, Peschke P, Huber PE, Hennink WE, Storm G. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug Biomaterials. 2009 Jul 1;30(20):3466-75. Available from: doi.org/10.1016/j.biomaterials.2009.02.040
  30. Chavhan SS, Petkar KC, Sawant Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2011;28(5). Available from: doi.org/10.2 174%2F1872211313666190614151615
  31. Zelikin AN, Ehrhardt C, Healy Materials and methods for delivery of biological drugs. Nature chemistry. 2016 Nov;8(11):997-1007.Salústio PJ, Ponte. Available from: doi. org/10.1038/nchem.2629
  32. Salústio PJ, Pontes P, Conduto C, Sanches I, Carvalho C, Arrais J, Marques Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. Aaps Pharmscitech. 2011 Dec;12:1276-92. Available from: doi.org/10.1208/s12249- 011-9690-2
  33. Surve DH, Jindal Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs. Journal of Controlled Release. 2020 Aug 10; 324:379-404. Available from: doi.org/10.1016/j.jconrel.2020.05.022
  34. Kakad SP, Gangurde TD, Kshirsagar SJ, Mundhe Nose to brain delivery of nanosuspensions with first line antiviral agents is alternative treatment option to Neuro-AIDS treatment. Heliyon. 2022 Jul 1;8(7). Available from: doi.org/10.1016/j. heliyon. 2022.e09925
  35. Taha JH, Abbas NK, Al-Attraqchi AA. Green Synthesis and Evaluation of Copper Oxide Nanoparticles using Fig Leaves and their Antifungal and Antibacterial Activities. Int. J. Drug Delivery 2020; 10:378-82. http://dx.doi.org/10.25258/ ijddt.10.3.13
  36. Mohammady M, Yousefi G. Freeze-drying of pharmaceutical and nutraceutical nanoparticles: The effects of formulation and technique parameters on nanoparticles Journal of pharmaceutical sciences. 2020 Nov 1;109(11):3235-47. Available from: doi.org/10.1016/j.xphs.2020.07.015
  37. Jacob S, Nair AB, Shah Emerging role of nanosuspensions in drug delivery systems. Biomaterials research. 2020 Dec;24:1-6. Available from: doi.org/10.1186/s40824-020-0184-8
  38. Zillen D, Beugeling M, Hinrichs WL, Frijlink HW, Grasmeijer Natural and bioinspired excipients for dry powder inhalation formulations. Current Opinion in Colloid & Interface Science. 2021 Dec 1;56:101497. Available from: doi.org/10.1016/j. cocis.2021.101497
  39. Sirapanichart S, Khouchaf L, Siriphannon P, Monvisade P, Louarn G, Elouadi Chemical and Dielectric Study of PMMA/ Montmorionite Nano-Composite Films. Ferroelectrics. 2010 Oct 29;402(1):47-54. http://dx.doi.org/10.1080/00150191003697344
  40. Carvalho DD, Takeuchi KP, Geraldine RM, Moura CJ, Torres MC. Production, solubility and antioxidant activity of curcumin Food Science and Technology. 2015 Jan;35:115-Available from: doi.org/10.1590/1678-457X.6515
  41. Liu Y, Li Y, Xu P, Shen Y, Tang B, Wang Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation. Pharmaceutics. 2022 May 26;14(6):1134. Available from: doi.org/10.3390/pharmaceutics14061134
  42. Li W, Yang Y, Tian Y, Xu X, Chen Y, Mu L, Zhang Y, Fang Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension. International journal of pharmaceutics. 2011 Apr 15;408(1-2):157-62. Available from: doi.org/10.1016/j.ijpharm.2011